Cora Griffin

Cora joined ReViral in May 2021 after 2 years of consulting for the Company. She is also a co-founder of ReViral. Cora is an experienced Business Development and Licensing professional with a proven track record in therapeutics and platform-based partnering. For 7 years, Cora worked as an independent BD consultant with a number of biotech companies including the Finnish company DelSiTech and Orbit Discovery in Oxford, UK. She held the position of BD Manager at the drug delivery company Q Chip, which was later acquired by Midatech. Cora began her BD career when she joined the antiviral company Arrow Therapeutics, following its acquisition by AstraZeneca. During this time, Cora was also a member of the AZ Strategic Planning and Business Development team. Cora obtained her Ph.D. in Virology at the College of Medicine, Cardiff University, and held a postdoctoral position at University College London.